血液凝固分析装置の世界市場規模：地域別、範囲および予測

血液凝固分析装置の市場規模と予測

血液凝固分析装置の市場規模は、2024年に40億7,000万米ドルと評価され、2024年～2031年の間に5.90％のCAGRで成長する見込みで2031年には64億3,000万米ドルに達すると予測されます。血液凝固分析装置は、血液の凝固能力を評価する特殊な医療機器であり、不正出血や凝固を伴う疾患の特定と治療に不可欠です。その他の活動では、プロトロンビン時間（PT）、活性化部分トロンボプラスチン時間（aPTT）、フィブリノゲン値など、さまざまな凝固パラメータを評価します。この知見は、抗凝固薬投与中の患者のモニタリング、血友病などの凝固性疾患の診断、深部静脈血栓症や肺塞栓症などの疾患の管理においてヘルスケアプロバイダーを支援します。正確でタイムリーなデータを提供することで、これらの技術は効果的で安全な患者ケアの確保に役立ちます。

血液凝固分析装置は、技術の向上と個別化治療に対する需要の高まりにより、明るい展望を抱いています。ポイントオブケア検査、電子カルテとの統合、家庭用小型化により、凝固検査の簡便性と精度が向上すると予測されます。

さらに、詳細な検査とリアルタイムのモニタリングが可能な、より複雑な分析装置の開発により、患者の転帰が改善され、臨床業務が合理化されると思われます。ヘルスケア産業が発展するにつれ、これらの分析装置は凝固疾患の治療と精密医療の発展に不可欠なものとなると思われます。

血液凝固分析装置の世界市場力学

血液凝固分析装置の世界市場を形成している主な市場力学

主な市場促進要因

血液疾患の有病率の増加：

血液疾患の有病率の増加：血液凝固分析装置は、患者における血液疾患の有病率の増加により高い需要があります。世界血友病連盟の年次世界調査2019によると、世界の血友病患者は32万4,000人を超え、前年比7%増でした。

老年人口の増加：

世界人口の高齢化に伴い、心血管疾患や凝固障害のリスクが高まり、凝固検査に対する需要が増加しています。国連の「World Population Prospects 2019」報告書によると、2050年までに世界の6人に1人が65歳以上になり、2019年の11人に1人から増加します。

外科手術の増加：

世界の外科手術の増加により、術前・術後ケアのための凝固検査がより多く必要とされています。2021年にランセット誌に発表された報告によると、世界中で行われた外科手術の件数は2008年から2018年の間に38.2％増加し、毎年3億1,300万件に達しています。

凝固分析装置の技術的進歩：

精度の向上や結果の迅速化など、血液凝固分析装置の技術的進歩が市場拡大の原動力となっています。2022年の米国立衛生研究所（NIH）の報告書によると、一般的な検査室での処置には30～60分かかるのに対し、ポイントオブケア凝固検査装置ではすでに1～3分程度で結果が得られるようになっています。

主な課題

技術の複雑さ：

血液凝固分析装置は、高度な技術と精密工学を必要とする複雑な装置です。精度と信頼性を維持しながら、急速な技術進歩に対応することは難しいかもしれません。競争力を維持するためには、メーカーは常にシステムを革新し、アップグレードする必要があり、そのためには研究開発に多額の費用が必要となります。

データ管理：

最新の凝固分析装置では膨大な量のデータが生成されるため、これらのデータは慎重に記録、保存、処理されなければなりません。結果を確実に信頼できるものとし、容易にアクセスできるようにするためには、効果的なデータ管理システムが不可欠です。これらの技術を他の病院情報システムと統合することは困難な場合があります。

製品の校正とメンテナンス：

凝固分析装置の精度と信頼性を確保するためには、定期的な校正と保守が必要です。この継続的な必要性は、特にリソースが限られているヘルスケア施設にとっては困難であり、これらの機器を採用することによる業務効率やコストに影響を及ぼす可能性があります。

高コスト：

血液凝固分析装置は、購入にも維持にも費用がかかります。これには機器本体、消耗品、定期的な校正や保守の必要性などが含まれます。このような高価格は、小規模の診療所や検査室にとっては法外であり、高度な凝固診断へのアクセスを制限します。

主な動向

ポイントオブケア検査

血液凝固のPOC（ポイント・オブ・ケア）検査は、サンプルを中央検査室に送るのではなく、その場で迅速に結果が得られるため、人気が高まっています。この動向の背景には、より迅速な診断結果と患者の利便性の向上に対する要望があります。POC機器は小型化し、より使いやすくなっているため、救急外来や外来診療所などさまざまな臨床現場で迅速な意思決定が可能になっています。

電子カルテ（EHR）との統合：

血液凝固分析装置と電子カルテ（EHR）との連携は、データ管理の迅速化と患者ケアの向上のためにますます増えています。このインターフェースにより、スムーズなデータ転送、患者情報へのリアルタイムアクセス、ヘルスケアプロバイダー間の連携が改善され、凝固検査および管理の全体的な効率が向上します。

小型化と携帯性：

小型で携帯可能な血液凝固分析装置の開発は大きなトレンドです。これらの小型機器は汎用性と簡便性を備えており、遠隔地や在宅医療などさまざまな状況での凝固検査が可能です。携帯型分析装置は、分散した検査ソリューションに対する需要の高まりに対応するものです。

高度な技術と自動化：

血液凝固分析装置は、自動化と技術の進歩により有用性が高まっています。自動化されたサンプルハンドリング、データ処理、結果報告などの機能がますます一般的になり、精度が向上し、手作業によるミスがなくなり、検査スループットが向上しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 血液凝固分析装置市場：分析装置タイプ別

• 臨床検査分析装置
• ポイントオブケア（POC）分析装置

第5章 血液凝固分析装置市場：用途別

• 定期凝固検査
• 特殊凝固検査
• 血栓症検査
• その他のアプリケーション

第6章 血液凝固分析装置市場：エンドユーザー別

• 病院
• 診療所および医師事務所
• 診断センター
• 研究機関

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Maccura Biotechnology Co. Ltd.
• Diagnostica Stago SAS
• Helena Laboratories

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Blood Coagulation Analyzer Market Size And Forecast

Blood Coagulation Analyzer Market size was valued at USD 4.07 Billion in 2024 and is projected to reach USD 6.43 Billion by 2031 , growing at a CAGR of 5.90% from 2024 to 2031. A blood coagulation analyzer is a specialized medical instrument that evaluates the blood's ability to clot, which is critical in identifying and treating disorders involving irregular bleeding or clotting. These analyzers assess a variety of coagulation parameters, including prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels, among others. The findings assist healthcare providers in monitoring patients undergoing anticoagulant medication, diagnosing clotting diseases such as hemophilia, and managing illnesses such as deep vein thrombosis and pulmonary emboli. By providing precise and timely data, these technologies help to ensure effective and safe patient care.

The blood coagulation analyzers look positive, thanks to technological improvements and rising demand for individualized therapy. Point-of-care testing, integration with electronic health records, and home miniaturization are all predicted to improve the ease and accuracy of coagulation tests.

Furthermore, the development of more complex analyzers capable of thorough testing and real-time monitoring is likely to enhance patient outcomes and streamline clinical operations. As the healthcare industry evolves, these analyzers will be critical to the treatment of coagulation diseases and the growth of precision medicine.

Global Blood Coagulation Analyzer Market Dynamics

The key market dynamics that are shaping the global blood coagulation analyzer market include:

Key Market Drivers:

Increasing Prevalence of Blood Disorders:

Blood coagulation analyzers are in high demand due to the increasing prevalence of blood diseases among patients. According to the World Federation of Hemophilia's Annual Global Survey 2019, there were over 324,000 people with hemophilia globally, up 7% over the previous year.

Rising Geriatric Population:

As the world's population ages, there is a greater risk of cardiovascular disease and clotting disorders, increasing the demand for coagulation tests. According to the United Nations' World Population Prospects 2019 report, by 2050, one in every six persons worldwide will be over the age of 65, up from one in every eleven in 2019.

Increasing Surgical Procedures:

Increasing surgical procedures worldwide need more coagulation tests for pre- and post-operative care. According to a report published in The Lancet in 2021, the number of surgical procedures performed worldwide increased by 38.2% between 2008 and 2018, reaching 313 million each year.

Technological Advancements in Coagulation Analyzers:

Technological advances in blood coagulation analyzers, including increased accuracy and faster results, are driving market expansion. According to a 2022 National Institutes of Health (NIH) report, point-of-care coagulation testing equipment can already offer results in as little as 1-3 minutes, compared to typical laboratory procedures that take 30-60 minutes.

Key Challenges:

Technological Complexity:

Blood coagulation analyzers are complex instruments that require advanced technology and precision engineering. It might be difficult to keep up with rapid technological advances while maintaining accuracy and reliability. To remain competitive, manufacturers must consistently innovate and upgrade their systems, which requires major expenditure in R&D.

Data Management:

Modern coagulation analyzers generate a huge amount of data, which must be carefully recorded, stored, and processed. Effective data management systems are essential for ensuring that results are dependable and easily accessible. Integrating these technologies with other hospital information systems can be difficult.

Product Calibration and Maintenance:

Regular calibration and maintenance are required to ensure the accuracy and reliability of coagulation analyzers. This continual necessity can be difficult, particularly for healthcare facilities with limited resources, and may impact the operational efficiency and cost of employing these devices.

High Costs:

Blood coagulation analyzers can be expensive both to purchase and to maintain. This includes the cost of the equipment, consumables, and the necessity for periodic calibration and servicing. These high prices can be prohibitive for smaller clinics and laboratories, restricting access to advanced coagulation diagnostics.

Key Trends:

Point-of-Care Testing:

Point-of-care (POC) testing for blood coagulation is becoming more popular, as it provides quick, on-site results rather than sending samples to a central lab. This trend is motivated by the desire for faster diagnostic results and more patient convenience. POC devices are becoming smaller and more user-friendly, allowing for rapid decision-making in a variety of clinical settings, including emergency rooms and outpatient clinics.

Integration with Electronic Health Records (EHRs):

Blood coagulation analyzers are increasingly being linked to electronic health records (EHRs) to expedite data administration and improve patient care. This interface offers smooth data transfer, real-time access to patient information, and improved coordination among healthcare providers, hence increasing the overall efficiency of coagulation testing and management.

Miniaturization and Portability:

The development of small and portable blood coagulation analyzers is a major trend. These small instruments provide versatility and simplicity, enabling coagulation testing in a variety of contexts, including remote locations and home care settings. Portable analyzers address the growing demand for dispersed testing solutions.

Advanced Technology and Automation:

Blood coagulation analyzers are becoming more useful as a result of advances in automation and technology. Features such as automated sample handling, data processing, and result reporting are becoming increasingly common, enhancing accuracy, eliminating manual errors, and increasing test throughput.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blood Coagulation Analyzer Market Regional Analysis

Here is a more detailed regional analysis of the global blood coagulation analyzer market:

North America:

North America continues to lead the blood coagulation analyzer market due to its excellent healthcare infrastructure, cutting-edge medical research, and the high prevalence of chronic disorders that necessitate regular coagulation monitoring. The region's well-established healthcare system promotes the widespread use of sophisticated diagnostic instruments, such as blood coagulation analyzers. According to the CDC, almost 900,000 Americans suffer from deep vein thrombosis or pulmonary embolism each year, with up to 100,000 deaths attributed to these illnesses. This high incidence highlights the urgent necessity for precise and rapid coagulation testing. The American Heart Association's 2024 update states that cardiovascular disorders affect roughly half of American adults, with many requiring continuing anticoagulant medication, increasing the requirement for dependable coagulation monitoring.

North America's enormous investments in medical technology and research strengthen its market supremacy. According to the National Institutes of Health, the region will account for more than 40% of worldwide healthcare R&D spending in 2023, with a large share going toward diagnostic technology such as blood coagulation analyzers. A growing emphasis on preventive healthcare and early detection is also a crucial driver, as indicated by a 2024 study that predicts an 8.5% annual growth rate in point-of-care coagulation testing across North America. This emphasis on rapid and accessible diagnostic solutions continues to drive market growth, establishing North America's dominant position in the blood coagulation analyzer sector.

Asia Pacific:

The Asia-Pacific area is rapidly emerging as the fastest-growing market for blood coagulation analyzers, owing to several revolutionary forces that are transforming the healthcare environment. Cardiovascular disorders account for 31% of all deaths in the region and about 6.2 million deaths per year, the extreme need for enhanced coagulation monitoring. This high prevalence contributes significantly to the rising demand for blood coagulation analyzers. The region's aging population is driving market growth. The United Nations Economic and Social Commission for Asia and the Pacific predicts that the number of older people in the region will quadruple by 2050, increasing the prevalence of age-related coagulation diseases and driving up the need for monitoring systems.

Rising healthcare expenditure in Asia-Pacific is also driving market expansion. This increased investment promotes the expansion of healthcare infrastructure and the availability of advanced diagnostic technology. Improved access to healthcare services for the region's growing middle class, combined with technology developments and improved awareness of blood problems, is fueling market growth. According to reports, point-of-care coagulation testing equipment use in India is growing at a 12% yearly rate, suggesting a regional trend toward rapid and accessible diagnostic options.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blood Coagulation Analyzer Market: Segmentation Analysis

The Global Blood Coagulation Analyzer Market is Segmented on the basis of Technology, Test Type, Distribution Channel, And Geography.

Blood Coagulation Analyzer Market, By Technology

• Optical Technology
• Mechanical Technology
• Electrochemical Technology

Based on Technology, the market is bifurcated into Optical Technology, Mechanical Technology, and Electrochemical Technology. Optical technology leads the blood coagulation analyzer market due to its great sensitivity, accuracy, and convenience. This method uses light to measure coagulation parameters, providing accurate and consistent results. On the other hand, electrochemical technology is emerging as the fastest-growing segment, given to its potential for downsizing and point-of-care applications. This method uses electrical signals to measure coagulation parameters, allowing for portable and convenient quick testing in a variety of scenarios.

Blood Coagulation Analyzer Market, By Test Type

• APTT
• D-Dimer
• Fibrinogen
• PT

Based on Test Type, the market is segmented into APTT, D-Dimer, Fibrinogen, and PT. The blood coagulation analyzer market is divided into two dominating segments: APTT and PT. APTT assesses the internal process of coagulation, whereas PT evaluates the extrinsic pathway. These tests are commonly used to assess patients with bleeding or clotting issues. D-dimer is a new segment that is quickly gaining popularity due to its significance in identifying deep vein thrombosis (DVT) and pulmonary embolism (PE). The rising prevalence of these disorders, combined with the development of more sensitive D-dimer testing, has accelerated its expansion.

Blood Coagulation Analyzer Market, By Distribution Channel

• Clinical Laboratory
• Point-of-Care (POC)
• Hospitals

Based on Distribution Channel, the market is segmented into Clinical Laboratory, Point-of-Care (POC), and Hospitals. Hospitals dominate the blood coagulation analyzer market due to requiring extensive testing for a diverse spectrum of patients. However, point-of-care (POC) testing is emerging as the most rapidly rising area. POC devices provide fast outcomes at the bedside, allowing for timely decision-making in critical care settings. The growing demand for decentralized testing, combined with technological developments in POC analyzers, is propelling their implementation in a variety of healthcare settings.

Blood Coagulation Analyzer Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Blood Coagulation Analyzer Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America continues to dominate the blood coagulation analyzer market due to its established healthcare infrastructure, advanced medical research, and high prevalence of chronic disorders. However, Asia-Pacific is emerging as the fastest-growing area, owing to reasons such as rising healthcare spending, increased awareness of blood coagulation disorders, and the expansion of healthcare infrastructure.

Key Players

• The "Global Blood Coagulation Analyzer Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., Maccura Biotechnology Co. Ltd., Diagnostica Stago SAS, and Helena Laboratories.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Blood Coagulation Analyzer Market Recent Developments
• In July 2022, HORIBA Medical will release the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a line of handy ready-to-use reagents for common blood coagulation assays. With the growth of its product line, HORIBA Medical now offers a full array of hemostasis systems and innovative reagents to laboratories of all sizes and needs.
• In October 2021, Trivitron Healthcare announced the launch of a new line of Coagulation Analyzer products developed by Diagon Ltd. The newly announced product line includes the COAG Line, which includes automated, semi-automated, and POC systems developed by Diagon Hungary. These cutting-edge technologies are critical in decreasing bleeding risks during extensive procedures, as well as evaluating the efficacy of hemostatic treatments and anticoagulants.
• In October 2021, Trivitron Healthcare, a medical device business, unveiled a new line of Coagulation Analyzer products in India, produced by Diagon Ltd.
• In February 2021, Siemens Healthineers and Sysmex Corporation announced the renewal of their long-standing global supply, distributorship, sales, and service agreement for a broad portfolio of hemostasis devices, which included a multi-year extension.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Blood Coagulation Analyzer Market, By Type of Analyzer

• Clinical Laboratory Analyzers
• Point-of-Care (POC) Analyzers

5. Blood Coagulation Analyzer Market, By Application

• Routine Coagulation Tests
• Special Coagulation Tests
• Thrombophilia Testing
• Other Applications

6. Blood Coagulation Analyzer Market, By End-User

• Hospitals
• Clinics and Physician Offices
• Diagnostic Centers
• Research Institutes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Maccura Biotechnology Co. Ltd.
• Diagnostica Stago SAS
• Helena Laboratories

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References